Roderick MacLeod Appointed Chief Financial Officer of Nevro

Roderick MacLeod has been appointed Chief Financial Officer of Nevro Corp, effective June 15, 2020, with global responsibility for Finance, IT and Customer Service.  Mr. MacLeod succeeds Andrew Galligan, who is retiring but will remain with the Company during a transition period.

“Roderick MacLeod is a proven leader with a track record of success in finance and operations leadership.  We are pleased that Rod is joining the Nevro executive team at a point in our history where his extensive financial, strategic and industry experience will help us accelerate toward long-term sustainable growth and strong financial performance for our shareholders,” said D. Keith Grossman, Chairman, CEO and President, Nevro.

“I’m very pleased to join Nevro and I view this as an exciting opportunity to continue to build a great company while helping patients who suffer from chronic pain,” said Rod MacLeod.  “I look forward to working closely with Keith and the rest of the Nevro team to execute on the Company’s growth strategy.”

Regarding Andrew Galligan’s retirement Grossman added, “Nevro has benefitted tremendously from Andrew’s leadership over the past decade and he has played a vital role in establishing a solid financial and operational foundation for the Company.  On behalf of the entire organization, I want to thank Andrew for his many accomplishments as CFO.  I also want to thank Andrew personally for being a great resource for me as I came on board, and for remaining with the Company during this transition period.”

“I’d like to thank Keith and the entire Nevro team – it’s truly been an honor to be a part of Nevro for these ten years,” said Andrew Galligan, Chief Financial Officer, Nevro.  “I’m proud of all that we’ve accomplished together and I’m confident that the Company is well positioned for future growth and success.”

Roderick MacLeod joins Nevro with more than 25 years of experience in financial and executive leadership roles in healthcare and technology.  Most recently he served as Vice President of Finance of Stryker Endoscopy, a $1.8 billion division of Stryker Corp that develops and manufactures medical devices used in minimally invasive surgical procedures.  During his 16-year career at Stryker Endoscopy, Mr. MacLeod played a key role in growing the division from $500 million to $1.8 billion in revenue.  Prior to this role, Mr. MacLeod was Controller for Stryker Endoscopy.  Previously, Mr. MacLeod was Vice President of Finance and Administration at Lumenare Networks, a Sunnyvale-based software company.  Earlier in his career, Mr. MacLeod was Financial Manager/Controller at United Airlines and was a Senior Operational and Audit Consultant at Arthur Andersen & Co.  Rod MacLeod graduated from the J.L. Kellogg Graduate School of Management at Northwestern University with a Master of Management degree and received his Bachelor of Arts degree in Economics from Harvard University.

SourceNevro

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.